Green Cross Health (NZX: GXH) - Director Appointment

Wednesday 6th April 2022

Green Cross Health announces the appointment of Craig Brockliss to the Board, effective 6 April 2022. Mr Brockliss will stand for election at the Annual Shareholders’ Meeting currently scheduled to be held on 25 July 2022.

In accordance with Rule 2.6.1 of the NZX Listing Rules, the Board has determined that Mr Brockliss is a non-independent director due to a disqualifying relationship with substantial product holder Wilton Asset Management Limited, currently the third largest Green Cross Health shareholder.

Craig Brockliss is CEO of the Wilton Capital Group of companies and has more than 20 years’ experience in business, property and private equity investing. Wilton Capital has significant investment interests in both New Zealand, the United States and in the UK.

Wilton Capital has its origins in the pharmaceutical logistics markets in New Zealand and Australia before diversifying into other investments in 2001.

Craig holds a Bachelor of Commerce and a Bachelor of Laws from the University of Auckland and worked for Ernst and Young prior to joining the Wilton Group in 2001.

Kim Ellis

Chair

ENDS

Director appointment - Craig Brockliss

Comments from our readers

No comments yet